Recently diagnosed with HIV? Click here

Treating HIV

Call for Tenders - Evaluation of the NSW HIV Community Prescribers Program

ASHM - 6 min 35 sec ago

ASHM invites the submission of tenders to review the NSW Community HIV s100 Prescriber Program.

Use of some anti-HIV drugs during pregnancy linked to cleft lip and palate; investigators urge cautious interpretation of results

HIV Media Digest - 10 February 2012 - 8:30am
US investigators have identified a possible association between the use of antiretroviral therapy during pregnancy and an increased risk of having a baby with a cleft lip or palate. The study, published in the January edition of Cleft Palate-Craniofacial Journal, found preliminary evidence seven anti-HIV drugs may increase the risk of this birth abnormality.

Merck says hepatitis pill hampers HIV Drugs

HIV Media Digest - 10 February 2012 - 8:22am
Merck & Co's recently approved Victrelis treatment for hepatitis C considerably lessens the effectiveness of some widely used medicines against the virus that causes AIDS, Merck and U.S. regulators said in separate reports.

Use of some anti-HIV drugs during pregnancy linked to cleft lip and palate; investigators urge cautious interpretation of results

Aidsmap - 10 February 2012 - 2:10am
US investigators have identified a possible association between the use of antiretroviral therapy during pregnancy and an increased risk of having a baby with a cleft lip or palate. The study, published in the January edition of Cleft Palate-Craniofacial Journal, found preliminary evidence seven anti-HIV drugs may increase the risk of this birth abnormality. However, the

Increased risk of anal cancer for all groups with HIV

HIV Media Digest - 9 February 2012 - 3:10pm
Gay men are not the only group of HIV-positive patients who have an increased risk of anal cancer, according to North American research published in the online edition of Clinical Infectious Diseases. The researchers found that incidence of the cancer was also significantly higher in non-gay HIV-positive men as well as HIV-positive women when compared to individuals in the general population.

Increased risk of anal cancer for all groups with HIV

Aidsmap - 8 February 2012 - 9:10pm
Gay men are not the only group of HIV-positive patients who have an increased risk of anal cancer, according to North American research published in the online edition of Clinical Infectious Diseases. The researchers found that incidence of the cancer was also significantly higher in non-gay HIV-positive men as well as HIV-positive women when

Controversy on Publication of AIDS Denialism Paper Continues

Poz - 8 February 2012 - 4:00pm
A member of the Italian Journal of Anatomy and Embryology editorial board has resigned over the publication of a paper written by longtime AIDS denialist Peter Duesberg that says there is no link between HIV and AIDS, Nature reports.

US CDC recommends HPV vaccine for young men

Aidsmap - 6 February 2012 - 7:50pm
Young men and adolescent boys between the ages of 11 and 21 should be vaccinated against human papillomavirus, the cause of genital warts, anal and cervical cancer, the Advisory Committee on Immunization Practices has recommended, in a new Adult Immunization Schedule published in Annals of Internal Medicine. The committee also recommends that all gay

Gardasil protects against recurrence of pre-cancerous anal lesions in HIV-negative gay men

Aidsmap - 6 February 2012 - 7:30pm
The genital wart vaccine Gardasil significantly reduces the risk of high-grade pre-cancerous anal lesion recurrence in men who have sex with men, US investigators report in the online edition of Clinical Infectious Diseases. The vaccine reduced the risk of lesion recurrence by approximately 50% in the first two years after immunisation. There was some evidence that

For patients with HIV viral load is key in immune response to yellow fever vaccine

Aidsmap - 2 February 2012 - 7:10pm
Viral load is the only factor associated with a poorer antibody response to the yellow fever vaccine in patients with HIV, according to a French study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. For patients vaccinated after diagnosis with HIV, an undetectable viral load was the “unique determinant” of

HIV care providers in US struggling to cope with rising patient numbers

Aidsmap - 1 February 2012 - 7:40pm
HIV doctors in the US are struggling to meet the demands of a rising patient caseload, according to the findings of a national survey. Two-thirds of HIV treatment providers reported an increase in patient numbers, and a third reported difficulties being reimbursed for the care they provided. The second annual HealthHIV State of Primary

Awareness, Testing Needed to Curb Hep C Infections Among HIV-Positive Gay Men

HIV Media Digest - 1 February 2012 - 9:02am
A new report by the National AIDS Trust (NAT), a leading HIV organization in the United Kingdom, concludes that much more needs to be done to address the burgeoning epidemic of hepatitis C virus (HCV) infection among gay men living with HIV.

Majority of HIV-positive patients in US not receiving regular medical care

HIV Media Digest - 1 February 2012 - 9:01am
Only 45% of HIV-positive patients in the US are receiving regular medical monitoring, research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests.

Rapid HIV test performance poorer with oral fluid than blood, especially when prevalence is low

Aidsmap - 26 January 2012 - 2:30am
The performance of OraQuick, a widely used rapid point-of-care test for HIV diagnosis, is slightly poorer when testing oral fluid samples than when testing blood samples, according to a meta-analysis published in the online edition of Lancet Infectious Diseases this week.The authors also found that if the test is used in low-prevalence settings with oral

Vitamin D supplements benefit bone metabolism of younger patients taking tenofovir

Aidsmap - 26 January 2012 - 2:00am
Vitamin D supplementation is associated with an improvement in a key marker of bone health in HIV-positive young adults treated with tenofovir, US research published in Clinical Infectious Diseases shows. Treatment with vitamin D3 lead to a significant fall in parathyroid hormone levels, an important regulator of calcium which has a significant role in bone metabolism.

Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?

Aidsmap - 21 January 2012 - 3:40am
In a bid to reduce the risk of nevirapine resistance after the use of single-dose nevirapine to prevent mother-to-child HIV transmission, several research groups are now experimenting with the use of drugs that can speed up the clearance of nevirapine from the mother’s bloodstream after giving birth. For example, adding single dose-carbamazepine, a cheap, readily available anti-convulsant

Common side-effects of hepatitis C protease inhibitors: clinical management advice published

Aidsmap - 21 January 2012 - 2:30am
The addition of the protease inhibitors telaprevir or boceprevir to hepatitis C treatment regimens increases the risk of anaemia, according to a review article published in Liver International. The author also found that telaprevir treatment was associated with an increased risk of rash and itching as well as some anorectal symptoms. However, these side-effects were

Vitamin D May Protect Bone Health in Tenofovir Takers

HIV Media Digest - 20 January 2012 - 8:31am
Vitamin D supplementation may help prevent hormonal changes that can lead to bone loss among adolescents and young adults being treated for HIV with tenofovir—found in Viread, Truvada and Atripla—according to a National Institutes of Health (NIH) study published online ahead of print by Clinical Infectious Diseases.

UN sees 'massive' fall in South Africa AIDS cases

HIV Media Digest - 20 January 2012 - 8:10am
South Africa, home to the highest number of HIV cases in the world, should see a massive reduction by the end of the decade after a sea-change in government policy, a UNAIDS official said Thursday.

Vigilance over early weight loss on HIV treatment needed, Tanzanian study shows

Aidsmap - 19 January 2012 - 4:10am
Nearly one-third of patients experienced substantial weight loss in the first ten months after starting antiretroviral therapy, leading American and Tanzanian researchers to warn that health care workers in resource-limited settings need to be on the look out for the ill effects of anaemia, malabsorption and malnutrition in patients starting antiretroviral therapy. Three months after starting ART
Syndicate content
Text size: font smallerfont normalfont larger

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.